Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pKM2L-phP14ARF (#RDB05510)

Promoter Bank clone, Human p14 alternative reding frame (ARF) promoter

Alternative name p1923-23F
Clone info. PCR amplified human p14 alternative reding frame (ARF) promoter sequence was inserted into a Renilla luciferase reporter vector pKM2L (RDB04026). Genomic sequence of 4728nt to 5703nt of AF082338.1 corresponding -922 to +54 (tanscription start site is designated +1. Fig.2B of Robertson, KD., Mol. Cell. Biol. 18 (11): 6457-6473, 1998) was PCR-amplified and then cloned.
Comment PCR cloning, forward primer, C7PB0051F: 5' agcgctcagatgctccgcggctg 3'; reverse primer, C7PB0051R: 5' gagctcggcagccgctgcgccg 3'.
Vector backbone pKM2L (RDB04026) (Plasmid)
Size of vector backbone 4.2 kb
Selectable markers Kan^r
Gene/insert name Human p14 alternative reding frame (ARF) genomic DNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 1. 本件リソースは学術研究機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB05510 pKM2L-phP14ARF DNA solution

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pKM2L-phP14ARF was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05510).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB05510_A8Bmp1.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: M13_-40 ()
Sequence file: RDB05510_A8Bma.seq check
>05510_05510_A8Bm_M13_-40_A01_01_ABI08.ab1
    1 AAGCCAGGGC AAGCTTGGCA TGCCTGCAGG TCATTTAAAT AGGGATAACA GGGTAATGAT
   61 TAAGATCTCG AGCTCTAAGC TTCACATATG CATGCACTAG TGGCGGTGCT CAGATGCTCC
  121 GCGGCTGTCG TGAAGGTTAA AACCGAAAAT AAAAATGGGC TAGACACAAA GGACTCGGTG
  181 CTTGTCCCAG CCAGGCGCCC TCGGCGACGC GGGCAGCTGG GAGGGGAATG GGCGCCCGGA
  241 CCCAGCTGGG ACCCCCGGGT GCGACTCCAC CTACCTAGTC CGGCGCCAGG CCGGGTCGAC
  301 AGCTCCGGCA GCGCCAGCGC CGCGCCGTGT CCAGATGTCG CGTCAGAGGC GTGCAGCGGT
  361 TTAGTTTAAT TTCGCTTGTT TTCCAAATCT AGAAGAGGAG CGGAGCGGCT TTTAGTTCAA
  421 AACTGACATT CAGCCTCCTG ATTGGCGGAT AGAGCAATGA GATGACCTCG CTTTCCTTTC
  481 TTCCTTTTTC ATTTTTAAAT AATCTAGTTT GAAGAATGGA AGACTTTCGA CGAGGGGAGC
  541 CAGGAATAAA ATAAGGGGAA TAGGGGAGCG GGGACGCGAG CAGCACCAGA ATCCGCGGGA
  601 GCGCGGCTGT TCCTGGTAGG GCCGTGTCAG GTGACGGATG TAGCTAGGGG GCGAGCTGCC
  661 TGGAGTTGCG TTCCAGGCGT CCGGCCCCTG GGCCGTCACC GCGGGGCGCC CGCGCTGAGG
721 GTGGGAAGAT GGTGGTGGGG GTGGGGATCA TCTGG
//
Primer: phRLR2 ()
Sequence file: RDB05510_A8Bmb.seq check
>05510_05510_A8Bm_phRLR2_B01_02_ABI08.ab1
    1 AACATTCCTT TGTTTGACAA GCCCAGTTTC TATTGGTCTC CTTAAACCTG TCTTGTAACC
   61 TTGATACTTA CCTGCCCAGT GCCTCACGAC CAACTTCTGC AGTACCCGGG TGAATTCTAC
  121 GCGTCGACAG GCGAGCTCGG CAGCCGCTGC GCCGCCCTTT GGCACCAGAG GTGAGCAGCG
  181 CCACTCCTGC CCCCTTAACT GCAGACTGGG ACCCACGCAC CGCCCCCTGC CCATCTCCGC
  241 CCCGCAGGCG CGCACCCGCC TTCCCTGAGC GCGCCCGCCC CCCACCTTCA CCCCCACCCC
  301 CACCCCACCC CCACTCCCAC CCGGACCTCC AAGATCTCGG AACGGCTCTG AGCCCTGCGC
  361 ACGCGGGAAG GGCTGCCGGA GGCGCCCGTA GGGAGGCGCG CGCGCGGGCG GCTCAGGGCC
  421 CGCGTTCCTC TCCCTCCCGC CTACCGCCAC TTTCCCGCCC TGTGTGCGCC CCCACCCCCA
  481 CCACCATCTT CCCACCCTCA GCGCGGGCGC CCCGCGGTGA CGGCCCAGGG GCCGGACGCC
  541 TGGAACGCAA CTCCAGGCAG CTCGCCCCCT AGCTACATCC GTCACCTGAC ACGGCCCTAC
  601 CAGGAACAGC CGCGCTCCCG CGGATTCTGG TGCTGCTCGC GTCCCCGCTC CCCTATTCCC
  661 CTTATTTTAT TCCTGGCTCC CCTCGTCGAA AGTCTTCCAT TCTTCAAACT AGATTATTTA
  721 AAAATGAAAA AGGAAGAAAG GAAAGCGAGG TCATCTCATT GCTCTATCCG CCAATCAGGA
  781 GGCTGAATGT CAGTTTTGAA CTAAAAGCCG CTCCGCTCCT CTTCTAGATT TGGAAAACAA
  841 GCGAAATTAA ACTAAACCGC TGCACGCCTC TGACGCGACA TCTGGACACG GCGCGGCGCT
  901 GGCGCTGCCG GAGCTGTCGA CCCGGCCTGG CGCCGGACTA GGTAGGTGGA GTCGCACCCG
  961 GGGGGTCCCA GCTGGGTCCG GGCGCCCATT CCCCTCCCAG CTGCCCGCGT CGCCGAGGGC
 1021 GCCTGCTGGG ACAAGCACCG AGTCCCTTTG GTGTCTAGCC CAATTTTTAT TTTCGGTTTT
 1081 AAACGTCACG GACAGCCGGC GGAGCCATCC TGAAGCACGG TCACTAGTGC AATGCCATAT
1141 GTGAAGCTTT AGAGCCTCGA AGAATCCTTA AATCCAGA
//
Primer: pAxCALNL_F1 ()
Sequence file: RDB05510_A8Bmc.seq check
>05510_05510_A8Bm_pAxCALNL_F1_C01_03_ABI08.ab1
    1 AAGTGATCTT ATATGTCTGC TCGAGCGGCC GCTCTAGAAT TACTGCTCGT TCTTCAGCAC
   61 GCGCTCCACG AAGCTCTTGA TGTACTTACC CATTTCATCT GGAGCGTCCT CCTGGCTGAA
  121 GTGGAGGCCC TTCACCTTCA CGAACTCGGT GTTAGGGAAC TTCTTAGCTC CCTCGACAAT
  181 AGCGTTGGAA AAGAACCCAG GGTCGGACTC GATGAACATC TTAGGCAGAT CGTCGCTGGC
  241 CCGAAGGTAG GCGTTGTAGT TGCGGACAAT CTGGACGACG TCGGGCTTGC CTCCCTTAAC
  301 GAGAGGGATC TCGCGAGGCC AGGAGAGGGT AGGCCGTCTA ACCTCGCCCT TCTCCTTGAA
  361 TGGCTCCAGG TAGGCAGCGA ACTCCTCAGG CTCCAGTTTC CGCATGATCT TGCTTGGGAG
  421 CATGGTCTCG ACGAAGAAGT TATTCTCAAG CACCATTTTC TCGCCCTCTT CGCTCTTGAT
  481 CAGGGCGATA TCCTCCTCGA TGTCAGGCCA CTCGTCCCAG GACTCGATCA CGTCCACGAC
  541 ACTCTCAGCA TGGACGATGG CCTTGATCTT GTCTTGGTGC TCGTAGGAGT AGTGAAAGGC
  601 CAGACAAGCC CCCCAGTCGT GGCCCACAAA GATGATTTTC TTTGGAAGGT TCAGCAGCTC
  661 GAACCAAGCG GTGAGGTACT TGTAGTGATC CAGGAGGCGA TATGAGCCAT TCCCGCTCTT
  721 GCCGGACTTA CCCATTCCGA TCAGATCAGG GATGATGCAT CTAGCCACGG GCTCGATGTG
  781 AGGCACGACG TGCCTCCACA GGTAGCTGGA GGCAGCGTTA CCATGCAGAA AAATCACGGC
  841 GTTCTCGGCG TGCTTCTCGG AATCATAGTA GTTGATGAAA GGAGTCCAGC ACGTTCATTT
  901 GCTTGCAGCG AGCCCACCAC TGAGGCCCAG TGATCATGCG TTTGCGTTGC TCGGGGGTCG
  961 TACACCTTGG AAAGCCATGG GTGGGCTAGC CTATAGTGAG TCGTATTTAA AGTACTCTAG
 1021 GCCTTAAGAG GCTTGTTAAT TTGAACTGGG GAGGTGGAAC ACCTGTTGGG AGAGAAAAGG
 1081 CAAAGTGGGA TGTAAGTAAA GACCAATAGG TTGCTTATCA GGAACGCAGG AGTCGTCTCT
1141 GGTCTCGACA AAGCCCAGTT TCTTATTTGG TCTTTA
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles